Main Article Content
Objective: To examine the relationship between the severity of polyneuropathy and nasal mucociliary clearance times in patients with polyneuropathy and investigate how the presence and severity of electrophysiological polyneuropathy might affect mucociliary clearance in patients with diabetes mellitus.
Material and Methods: This prospective cross-sectional study was carried out in the Neurol-ogy and Ear, Nose and Throat (ENT) clinics in a tertiary hospital. The study included three groups of patients with 20 participants in each group (Group 1, patients with diabetic poly-neuropathy; Group 2, patients with non-diabetic polyneuropathy; and Group 3, diabetes melli-tus patients with a normal nerve conduction study) Nasal saccharin test was performed on all patients.
Results: There was a statistically significant difference in the duration of nasal mucociliary clearance among the groups (p= 0.001). There was a positive, statistically significant (p = 0.007) correlation between the nasal mucociliary clearance duration and the severity of poly-neuropathy. The nasal mucociliary clearance duration increased with the severity of polyneuropathy.
Conclusion: Patients with diabetes mellitus are a special group, and preventable problems should be taken into consideration when examining nasal pathologies. It should be kept in mind that nasal mucociliary clearance dysfunction can be both a cause and a result in management of diabetes mellitus patients, and thus it should be evaluated carefully.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
2. Houtmeyers SE, Gosselink R, Gayan-Ramirez G, Decramer M. Regulation of mucociliaray clearence in health and disease. Eur respir J 1999; 13:1177-1188.
3. Xavier RF, Ramos D, Ito JT, Rodrigues FMM, Bertolini GN, Macchione M, et al. Effects of Cigarette Smoking Intensity on the Mucociliary Clearance of Active Smokers. Respiration 2013; 86:479-485.
4. Jiao J, Zhang L. Influence of Intranasal Drugs on Human Nasal Mucociliary Clearance and Ciliary Beat Frequency. Allergy Asthma Immunol Res. 2019;11(3):306–319.
5. Corbo GM, Foresi A, Bonfitto P, Mugnano A, Agabiti N, Cole PJ. Measurement of nasal mucociliary clearance. Arch Dis Child. 1989;64(4):546–550.
6. Grossan M. Mucociliary Clearance: Measures and Therapies. Otolaryngol (Sunnyvale) 2017;7: 336.
7. Rutland J, Cole PJ. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis. Thorax. 1981;36(9):654–658.
8. Yao A, Wilson JA, Ball SL. Autonomic nervous system dysfunction and sinonasal symptoms. Allergy Rhinol (Providence). 2018; 9:2152656718764233.
9. Yue WL. Nasal mucociliary clearance in patients with diabetes mellitus. The Journal of Laryngology and Otology 1989; 103: 853-55.
10. Proença de Oliveira-Maul J, Barbosa de Carvalho H, Goto DM, Maia RM, Fló C, Barnabé V, et al. Aging, diabetes, and hypertension are associated with decreased nasal mucociliary clearance. Chest. 2013 Apr;143(4) 1091-1097.
11. Deniz M, UsluC, Ogredik EA, AkdumanD, Gursan SO. Nasal mucociliary clearance in total laryngectomized patients. Eur Arch Otorhinolaryngol 2006; 263: 1099-1104.
12. Sahin E, Hamamcı M, Kantekin Y. Measurement of mucociliary clearance in the patients with multiple sclerosis. Eur Arch Otorhinolaryngol. 2020; 277(2) 469-473
13. Müller M, Betlejewski S. Nasal mucosa in patients with diabetes mellitus. Otolaryngol Pol. 2003; 57:361-364.
14. Zhang Z, Adappa ND, Lautenbach E, Chiu AG, Doghramji L, Howland TJ, et al. The effect of diabetes mellitus on chronic rhinosinusitis and sinus surgery outcome. Int Forum Allergy Rhinol. 2014 Apr;4(4):315-20.
15. Dinesh R, Avatar S, Haron A, Suhana MD, Azwarizan MD. Nasal septal abscess with uncontrolled diabetes mellitus: case reports. Med J Malaysia. 2011 ;66(3):253-4.
16. Sachdeva A, Sachdeva OP, Gulati SP, Kakkar V. Nasal mucociliary clearance & mucus pH in patients with diabetes mellitus. The Indian Journal of Medical Research. 1993; 98:265-268.
17. Selimoglu MA, Selimoglu E, Kurt A. Nasal mucociliary clearance and nasal and oral pH in patients with insulin-dependent diabetes. Ear, Nose, & Throat Journal. 1999; 78:585-588.
18. Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V, et al; Toronto Expert Panel on Diabetic Neuropathy. Toronto Expert Panel on Diabetic Neuropathy. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011; 27:620-628.
19. Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, et al.Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy. Clin Ther. 2018; 40:828–849.
20. Hicks CW, Selvin E. Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Curr Diab Rep. 2019; 19: 86.
21. Lee WJ, Jang S, Lee SH, Lee HS. Correlation Between the Severity of Diabetic Peripheral Polyneuropathy and Glycosylated Hemoglobin Levels: A Quantitative Study. Ann Rehabil Med. 2016;40(2):263–270.